167 related articles for article (PubMed ID: 27030398)
1. The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging.
Kumar JS; Miller Jenkins LM; Gottesman MM; Hall MD
Mol Imaging; 2016; 15():. PubMed ID: 27030398
[TBL] [Abstract][Full Text] [Related]
2. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.
Brewster ME; Hora MS; Simpkins JW; Bodor N
Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811
[TBL] [Abstract][Full Text] [Related]
3. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
Felton LA; Wiley CJ; Godwin DA
Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.
Huang R; Vider J; Serganova I; Blasberg RG
Mol Imaging; 2011 Jun; 10(3):215-26. PubMed ID: 21496450
[TBL] [Abstract][Full Text] [Related]
5. Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery.
Kear CL; Yang J; Godwin DA; Felton LA
Drug Dev Ind Pharm; 2008 Jul; 34(7):692-7. PubMed ID: 18608463
[TBL] [Abstract][Full Text] [Related]
6. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.
Inoue Y; Kiryu S; Izawa K; Watanabe M; Tojo A; Ohtomo K
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):771-9. PubMed ID: 19096841
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporter 1 (OAT1/SLC22A6) enhances bioluminescence based on d-luciferin-luciferase reaction in living cells by facilitating the intracellular accumulation of d-luciferin.
Furuya T; Takehara I; Shimura A; Kishimoto H; Yasujima T; Ohta K; Shirasaka Y; Yuasa H; Inoue K
Biochem Biophys Res Commun; 2018 Jan; 495(3):2152-2157. PubMed ID: 29273507
[TBL] [Abstract][Full Text] [Related]
8. Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system.
Li S; Ruan Z; Zhang H; Xu H
Eur J Med Chem; 2021 Feb; 211():113111. PubMed ID: 33360804
[TBL] [Abstract][Full Text] [Related]
9. A synthetic luciferin improves bioluminescence imaging in live mice.
Evans MS; Chaurette JP; Adams ST; Reddy GR; Paley MA; Aronin N; Prescher JA; Miller SC
Nat Methods; 2014 Apr; 11(4):393-5. PubMed ID: 24509630
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydroxypropyl-beta-cyclodextrin on the extraction and biodegradation of phenanthrene in soil.
Reid BJ; Stokes JD; Jones KC; Semple KT
Environ Toxicol Chem; 2004 Mar; 23(3):550-6. PubMed ID: 15285345
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
Usayapant A; Karara AH; Narurkar MM
Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.
Bakhsheshian J; Wei BR; Hall MD; Simpson RM; Gottesman MM
Methods Mol Biol; 2016; 1461():227-39. PubMed ID: 27424909
[TBL] [Abstract][Full Text] [Related]
13. The effect of 2-hydroxypropyl-beta-cyclodextrin on in vitro drug release of steroids from suppository bases.
Usayapant A; Iyer BR
Drug Dev Ind Pharm; 1999 Mar; 25(3):387-90. PubMed ID: 10071835
[TBL] [Abstract][Full Text] [Related]
14. Oatp1 enhances bioluminescence by acting as a plasma membrane transporter for D-luciferin.
Patrick PS; Lyons SK; Rodrigues TB; Brindle KM
Mol Imaging Biol; 2014 Oct; 16(5):626-34. PubMed ID: 24798747
[TBL] [Abstract][Full Text] [Related]
15. Solubilization of ovine growth hormone with 2-hydroxypropyl-beta-cyclodextrin.
Simpkins JW
J Parenter Sci Technol; 1991; 45(6):266-9. PubMed ID: 1802981
[TBL] [Abstract][Full Text] [Related]
16. Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.
Zhang Y; Pullambhatla M; Laterra J; Pomper MG
Mol Imaging; 2012; 11(6):499-506. PubMed ID: 23084250
[TBL] [Abstract][Full Text] [Related]
17. Applications of luciferin biosynthesis: Bioluminescence assays for l-cysteine and luciferase.
Niwa K; Nakajima Y; Ohmiya Y
Anal Biochem; 2010 Jan; 396(2):316-8. PubMed ID: 19748476
[TBL] [Abstract][Full Text] [Related]
18. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
[TBL] [Abstract][Full Text] [Related]
19. The estimation of PAH bioavailability in contaminated sediments using hydroxypropyl-beta-cyclodextrin and Triton X-100 extraction techniques.
Cuypers C; Pancras T; Grotenhuis T; Rulkens W
Chemosphere; 2002 Mar; 46(8):1235-45. PubMed ID: 11951991
[TBL] [Abstract][Full Text] [Related]
20. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
Zhang Y; Bressler JP; Neal J; Lal B; Bhang HE; Laterra J; Pomper MG
Cancer Res; 2007 Oct; 67(19):9389-97. PubMed ID: 17909048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
